Ivabradine as adjuvant treatment for chronic heart failure-Reference-Cited by-同舟云学术

Ivabradine as adjuvant treatment for chronic heart failure

Published:2020-11-04 Issue:11 Volume:2020 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Benstoem Carina¹,Kalvelage Christina¹,Breuer Thomas¹,Heussen Nicole²³,Marx Gernot¹,Stoppe Christian¹,Brandenburg Vincent⁴

Affiliation:

1. Department of Intensive Care Medicine; Medical Faculty, RWTH Aachen University; Aachen Germany

2. Department of Medical Statistics; Medical Faculty RWTH Aachen University; Aachen Germany

3. Center of Biostatistic and Epidemiology; Medical School, Sigmund Freud Private University; Vienna Austria

4. Department of Cardiology, Medical Faculty; University Hospital RWTH Aachen; Aachen Germany

Publisher

Wiley

Subject

Pharmacology (medical)

Reference193 articles.

1. Effects of adding ivabradine to optimal medical therapy in symptomatic patients with left ventricular systolic dysfunction secondary to ischemic or idiopathic dilated cardiomyopathy;Abdel;ESC Heart Failure,2011

2. Addition of ivabradin further improves clinical status in patients with end stage heart failure and intolerance to ss-blockers;Adamyan;Circulation,2008

3. Efficacy of long-term ivabradine therapy on prognosis, left and right heart functional parameters in patients with chronic heart failure and preserved left ventricular systolic function;Adamyan;European Heart Journal,2015

4. Importance of serum sodium in ischemic heart failure with systolic dysfunction;Bansal;European Journal of Heart Failure,2019

5. Effects of ivabradine on left ventricular function in patients with ischemic heart failure;Chaudhari;Indian Heart Journal,2014

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effect of ivabradine therapy on dilated cardiomyopathy patients with congestive heart failure: a systematic review and meta-analysis;Frontiers in Cardiovascular Medicine;2023-10-17

2. Ivabradine in patients with heart failure: a systematic literature review;Journal of Market Access & Health Policy;2023-10-04

3. Sex and Gender Appraisal Tool-Systematic Reviews-2 and Participation-To-Prevalence Ratio assessed to whom the evidence applies in sepsis reviews;Journal of Clinical Epidemiology;2022-02

4. Ivabradine added to usual care in patients with heart failure: a systematic review with meta-analysis and trial sequential analysis;BMJ Evidence-Based Medicine;2021-11-17

5. Soluble suppression of tumorigenesis-2 (sST2), a new potential biomarker of response to cardiac resynchronization therapy and cardiac contractility modulation in patients with chronic heart failure;Almanac of Clinical Medicine;2021-06-28